PACIRA BIOSCIENCES

Serial Number 88325887
606

Registration Progress

Application Filed
Mar 5, 2019
Under Examination
Sep 3, 2019
Approved for Publication
Jul 9, 2019
Published for Opposition
Jul 9, 2019
Registered

Trademark Image

PACIRA BIOSCIENCES

Basic Information

Serial Number
88325887
Filing Date
March 5, 2019
Published for Opposition
July 9, 2019
Abandonment Date
April 5, 2021
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 5, 2021
Classes
005 010 040 042

Rights Holder

Pacira Pharmaceuticals, Inc.

03
Address
5 Sylvan Way
Parsippany, NJ 07054

Ownership History

Pacira Pharmaceuticals, Inc.

Original Applicant
03
Parsippany, NJ

Pacira Pharmaceuticals, Inc.

Owner at Publication
03
Parsippany, NJ

Legal Representation

Attorney
Vanessa A. Ignacio, Esq.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

23 events
Date Code Type Description Documents
Apr 5, 2021 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Apr 5, 2021 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 22, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 20, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 20, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 20, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 4, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 2, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 2, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 2, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 3, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 9, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 9, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 19, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 30, 2019 ALIE A ASSIGNED TO LIE Loading...
May 16, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 16, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 16, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 16, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 16, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 14, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 22, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 8, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Analgesics; chemical preparations and reagents for pharmaceutical, medical, and veterinary clinic purposes, namely, pharmaceutical preparations for acute care treatment, namely, for the monitoring and treatment of pain and cancer; pharmaceutical preparations for post-surgical use
Class 010
Medical device, namely, an injectable cold temperature device for peripheral nerve treatment; Medical device for cryoanalgesic therapy
Class 040
Custom manufacture of medical goods, namely, drug delivery devices in the nature of implanted or topically applied aggregations of liposomes providing timed-release of encapsulated pharmaceuticals, made to the order or specification of others, for treatment of a wide variety of diseases
Class 042
Research and development of new surgical products, diagnostic products and medical treatments for others; scientific research and development services; development and engineering services in the field of surgical, diagnostic and therapeutic products; product development; design of new products for others; Design of medical goods for others, namely, drug delivery devices in the nature of implanted or topically applied aggregations of liposomes providing timed-release of encapsulated pharmaceuticals, made to the order or specification of others, for treatment of a wide variety of diseases

Classification

International Classes
005 010 040 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"